| Chromogranin A: is it a useful marker of neuroendocrine tumors? D Campana, F Nori, L Piscitelli, AM Morselli-Labate, R Pezzilli, ... Journal of Clinical Oncology 25 (15), 1967-1973, 2007 | 339 | 2007 |
| Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression F Panzuto, L Boninsegna, N Fazio, D Campana, M Pia Brizzi, G Capurso, ... Journal of Clinical Oncology 29 (17), 2372-2377, 2011 | 338 | 2011 |
| 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors V Ambrosini, D Campana, L Bodei, C Nanni, P Castellucci, V Allegri, ... Journal of Nuclear Medicine 51 (5), 669-673, 2010 | 308 | 2010 |
| Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours V Ambrosini, P Tomassetti, P Castellucci, D Campana, G Montini, ... European journal of nuclear medicine and molecular imaging 35, 1431-1438, 2008 | 306 | 2008 |
| Endocrine pancreatic tumors: factors correlated with survival P Tomassetti, D Campana, L Piscitelli, R Casadei, D Santini, F Nori, ... Annals of Oncology 16 (11), 1806-1810, 2005 | 243 | 2005 |
| Standardized uptake values of 68Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors D Campana, V Ambrosini, R Pezzilli, S Fanti, AMM Labate, D Santini, ... Journal of Nuclear Medicine 51 (3), 353-359, 2010 | 205 | 2010 |
| Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours P Tomassetti, M Migliori, S Lalli, D Campana, V Tomassetti, R Corinaldesi Annals of Oncology 12, S95-S99, 2001 | 157 | 2001 |
| 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET V Ambrosini, D Campana, P Tomassetti, S Fanti European journal of nuclear medicine and molecular imaging 39, 52-60, 2012 | 152 | 2012 |
| 68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours V Ambrosini, C Nanni, M Zompatori, D Campana, P Tomassetti, ... European journal of nuclear medicine and molecular imaging 37, 722-727, 2010 | 137 | 2010 |
| Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET … A Faggiano, P Ferolla, F Grimaldi, D Campana, M Manzoni, MV Davģ, ... Journal of endocrinological investigation 35, 817-823, 2012 | 135 | 2012 |
| Mechanisms involved in the onset of post-ERCP pancreatitis R Pezzilli, E Romboli, D Campana, R Corinaldesi Jop 3 (6), 162-8, 2002 | 132 | 2002 |
| Real-world study of everolimus in advanced progressive neuroendocrine tumors F Panzuto, M Rinzivillo, N Fazio, F de Braud, G Luppi, MC Zatelli, F Lugli, ... The oncologist 19 (9), 966-974, 2014 | 112 | 2014 |
| Prognostic value of 68Ga-DOTANOC PET/CT SUVmax in patients with neuroendocrine tumors of the pancreas V Ambrosini, D Campana, G Polverari, C Peterle, S Diodato, C Ricci, ... Journal of Nuclear Medicine 56 (12), 1843-1848, 2015 | 106 | 2015 |
| Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study MV Davi', E Cosaro, S Piacentini, G Reimondo, N Albiger, G Arnaldi, ... European journal of endocrinology 176 (4), 453-461, 2017 | 100 | 2017 |
| Warm water or oil-assisted colonoscopy: toward simpler examinations? E Brocchi, R Pezzilli, P Tomassetti, D Campana, AM Morselli-Labate, ... Official journal of the American College of Gastroenterology| ACG 103 (3 …, 2008 | 99 | 2008 |
| Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires R Pezzilli, AM Morselli-Labate, L Fantini, D Campana, R Corinaldesi Digestive and Liver Disease 39 (12), 1077-1086, 2007 | 95 | 2007 |
| Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin … JC Yao, J Strosberg, N Fazio, ME Pavel, P Ruszniewski, E Bergsland, ... Annals of Oncology 29, viii467-viii468, 2018 | 92 | 2018 |
| Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms JC Yao, J Strosberg, N Fazio, ME Pavel, E Bergsland, P Ruszniewski, ... Endocrine-related cancer 28 (3), 161-172, 2021 | 91 | 2021 |
| Everolimus in pancreatic neuroendocrine carcinomas G3 F Panzuto, M Rinzivillo, F Spada, L Antonuzzo, T Ibrahim, D Campana, ... Pancreas 46 (3), 302-305, 2017 | 89 | 2017 |
| Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? A single-center experience R Casadei, C Ricci, D Rega, M D'Ambra, R Pezzilli, P Tomassetti, ... Pancreas 39 (6), 825-828, 2010 | 89 | 2010 |
Stefano FantiProfessore di Diagnostica per ImmaginiVerified email at unibo.it
